Background: Breast malignancies encompass various subtypes which differ in their clinical presentations, outcomes, and response to the treatment regimens. Thus, a proper histological diagnosis and a special mention of the rare histologic subtypes are required to formulate clear recommendations of their treatment protocols. Materials and Methods: This is a 1-year retrospective study highlighting the rarely encountered subtypes on the mastectomy specimens received. Results: We encountered only 11 rare cases out of the total 153 mastectomy specimens received. The rare subtypes were as follows mucinous cystadenocarcinoma (0.6%), mucinous carcinoma (0.6%), dermatofibrosarcoma protuberans (0.6%), Squamous cell carcinoma (0.6%), papillary carcinoma (2.6%), medullary carcinoma (0.6%), and malignant mesenchymal tumor (1.3%). Conclusion: Our data suggest that these variants are distinct clinicopathological entities with a unique hormonal receptor status. Scant information is available on the rare breast tumor subtypes.
Introduction
I nvasive breast carcinomas are a group of malignant epithelial tumors characterized by invasion of the adjacent tissues and tendency to metastasis. The majority of these are adenocarcinomas derived from the terminal duct lobular unit. [1] The WHO categorizes the breast tumors in 21 distinct histological types on the basis of cell morphology and architecture. Invasive ductal carcinoma (IDC) of no special type (ductal) is the most common type of invasive breast cancer accounting for approximately 65%-80% of the invasive breast neoplasms. [1] [2] [3] The invasive lobular carcinoma lags behind IDC (second most common) and accounts for only 5%-15% of the disease burden. [2] [3] [4] A widely accepted fact that the aggressive nature of the breast cancer can be determined by its histological type, grade, nodal status, and metastasis holds the ground even in the era of immunohistochemistry (IHC) and molecular pathology. [5, 6] The histological diversity of breast carcinomas has relevant prognostic implications as the management of
Study design
This is a retrospective study in which the rare variants of breast tumors were highlighted using cytological, histopathological, and immunochemical techniques.
Materials and Methods
A 1-year study was conducted during the period of April 2017 to April 2018 on 153 mastectomy and lumpectomy specimens irrespective of the preoperative chemotherapy status. All the specimens were fixed in 10% formalin and were adequately grossed. The sections were stained using hematoxylin and eosin and were examined under a light microscope. IHC including estrogen receptor (ER), progesterone receptor (PR), HER2neu, and other markers was used, wherever necessary and applicable. The fine-needle aspiration slides of all the cases were reviewed retrospectively.
Results
The present study is a retrospective study of 153 cases. The patient's age ranged from 28 years to 85 years, and the mean was 52.9 ± 9.7 years. Of the total, 141 (92.1%) cases were reported as IDC. Only 11 (7.2%) cases were diagnosed as the rare histological variants of breast malignancy. These rare variants included papillary carcinoma (4), malignant mesenchymal tumor (2), mucinous carcinoma (1), mucinous cystadenocarcinoma (1), medullary carcinoma (1), SqCC (1), dermatofibrosarcoma protuberans (DFSP) (1) . The details of these rare histological variants including the case summaries, fine-needle aspiration cytology (FNAC) findings, and histopathological and IHC findings are highlighted in Table 1 . Herein, we are discussing all the important gross and histological features of the rare variants.
Mucinous cystadenocarcinoma
We received a mastectomy specimen measuring 12 cm × 10 cm × 6 cm with a mucinous grayish-white growth [ Figure 1 ]. On microscopy, numerous dilated mucin-filled cystic spaces lined by tall columnar cells with abundant intra-and extracytoplasmic mucin, basally placed nuclei, and inconspicuous nucleoli were seen. The cells were CK-7 positive and CK-20, ER, PR, and HER2neu negative. 
Dermatofibrosarcoma protuberans
A 47-year-female presented to surgery outpatient department (OPD) with a breast lump for which mastectomy was done [ Figure 2 ]. Serial sections through the specimen showed a grayish-white firm growth involving the overlying skin. On histopathological sections, a hypercellular tumor comprised monotonous oval-to-spindle cells resembling fibroblasts arranged in storiform pattern involving the dermis. On IHC, the cells were strongly positive for CD34 (4+).
Medullary carcinoma
A 49-year-old female presented to gynecology OPD with a 5 cm × 4 cm lump in the upper outer quadrant of the right breast. On serial slicing the mastectomy specimen, there was a large gray-white growth involving almost the entire breast. On microscopic examination, there were syncytial growth pattern, absence of gland formation, marked nuclear pleomorphism, and diffuse lymphoplasmacytic infiltrate. On IHC, the tumor was triple receptor negative and also negative for S-100 [ Figure 3 ].
Malignant mesenchymal tumor
Primary mesenchymal tumors are a rare malignancy of the breast. We encountered two female patients aged Figure 4 ]. The tumor cells were positive for vimentin and negative for S-100.
Mucinous carcinoma
A 38-year-old female presented with a lump which grossly was gelatinous in appearance with bosselated pushing margins. On histopathological examination, there were clusters of uniform round cells with minimal amount of eosinophilic cytoplasm floating in pools of mucin. These cells were positive for ER, PR, and CK-7 and negative for HER2neu and CK-20 [ Figure 5 ].
Squamous cell carcinoma
We received a mastectomy specimen of a 43-year-old female with a 15-cm × 14-cm lump in the right breast. The tumor was involving the entire breast and causing ulceration of the overlying skin and nipple areola complex. On microscopy, the tumor was comprised >90% cells which were well-differentiated squamous cells. Extensive keratin pearl formation was also appreciated [ Figure 6 ].
Papillary carcinoma
Over a period of 1 year, we encountered four cases of papillary carcinoma all of which were postmenopausal females. On microscopy, all the cases had well-formed papillae and absent myoepithelial cell layer. In one of the cases, we saw a mixed pattern, comprised IDC, extensive in situ carcinoma, comedocarcinoma, and invasive papillary component. Only one case was positive for ER, rest all were negative for ER, PR, and Her2neu [ Figure 7 ]. 
Discussion
The rare and the special histological variants of breast malignancies often have a peculiar clinical behavior. However, considering the underlying fact that due to the rarity of these malignancies, the therapeutic regimen formulations are greatly affected. As a consequence, the clear treatment guidelines and recommendations are lacking for these variants. [3] Herein, we are discussing the different types of breast malignancies which are rarely encountered on the day-to-day pathology practice.
Mucinous cystadenocarcinoma
An extremely rare variant of primary breast carcinoma belongs to the family of mucin-producing carcinoma sharing the same histology as the mucinous cystadenocarcinoma of the ovary and pancreas. [7] [8] [9] [10] [11] [12] [13] Similar to our case, most of these tumors are reported in postmenopausal females aged between 47 and 96 years. [7] [8] [9] [10] [11] [12] [13] Dermatofibrosarcoma protuberans DFSP is a mesenchymal neoplasm of the dermis and subcutis. It is a rare soft-tissue neoplasm, originally described in 1924 by Darier and Ferrand with a reported incidence of five cases per one million individuals per year. [14] [15] [16] This tumor rarely occurs in the breast and is the differential diagnosis includes other stromal tumors such as phyllodes tumor, pseudoangiomatous stromal hyperplasia, myofibroblastoma, leiomyoma, and periductal stromal sarcomas.
Medullary carcinoma
These represent <2% of breast carcinoma and occur frequently in the younger women. Despite their aggressive look, these have a good prognosis. [6, 17] Malignant mesenchymal tumor Primary mesenchymal tumors/malignant tumors originating from mesenchymal tissue are rare malignancy of the breast. The metaplastic carcinomas which are characterized by a combination of mesenchymal and epithelial components are uncommon malignancies of the breast. Pure primary sarcomas are the rarest malignancies in mammary tissue. Few of the reported sarcomas include primary chondrosarcoma, spindle cell sarcoma, neuroectodermal tumor, and angiosarcoma. [18] 
Mucinous carcinoma
Pure mucinous carcinomas (mucin component >90%) account for only about 2% of the breast carcinomas. Mucinous carcinoma of the breast is one of the rarer forms of intramammary cancer, often presenting as a lobulated, fairly well-circumscribed mass on mammography, sonography, and gadolinium-enhanced magnetic resonance imaging (MRI). It accounts for 1%-7% of all breast cancers and generally carries a better prognosis than other types of malignant breast cancers. Metastatic disease occurs at a lower frequency than in other types of invasive carcinoma. We present an atypical case of mucinous carcinoma in a woman who presented with a palpable intramammary lymph node metastasis from an unknown breast primary. Subsequent MRI and percutaneous biopsy demonstrated histologic findings consistent with a mixed mucinous neoplasm with a micropapillary pattern.
Invasive mucinous carcinoma of the breast is one of the rarer breast neoplasms and is typically associated with a better prognosis, a longer disease-free interval, and a lower incidence of axillary node metastasis. It often presents as a lobulated and/or well-circumscribed mass on mammography, sonography, and MRI. [1] 
Squamous cell carcinoma
Pure primary SqCC of the breast is a rare (<0.1%) and aggressive tumor. It is considered to arise from metaplastic change of the ductal carcinoma cells. [19, 20] This is a very aggressive, hormone receptor negative, and treatment refractory tumor with poor prognosis. The treatment of primary SqCC of the breast does not differ from other common histological types of breast cancer and may involve surgery, chemotherapy, hormonal therapy, and radiation therapy.
Papillary carcinoma
A rare variant of breast carcinoma comprises <2% of the breast malignancies. [21] It is predominantly seen in the postmenopausal women. Histologically, it is characterized by papillary lesion with absent myoepithelial cell layer. [21] [22] [23] 
Conclusion
Due to the rarity of these tumors, there is an extreme paucity of literature in this area. Most of the literature available is in the form of case reports. Herein, we highlighted these rare diagnosis taking into consideration the cytological, histopathological, and immunohistochemical findings. Thus, a proper histological diagnosis and a special mention of the rare histologic subtypes are required to formulate clear recommendations of their treatment protocols.
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